Brian Chei-Fai Lau, MD
Orthopedic Surgery · Durham
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 6
Offices
6 locations · Duke Health Integrated Practice Inc · Legacy Healthcare Services Inc
Looking this up.
Hospitals listed: Duke University Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Lau’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A132046 · Current
Licensed to practise in California · since 2014 · expires 2028-01-31 · University of Pittsburgh School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Duke University HospitalDurham, NCAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Duke University Health System, which runs 3 hospitalsHome of Duke Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Death rate among surgical inpatients with serious treatable complications: 216.01 (186.77 to 245.25) · 366 cases, Jul 2022 – Jun 2024Worse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.5 (4.26 to 6.75) · 6,581 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative acute kidney injury requiring dialysis rate: 2.95 (2.11 to 3.79) · 3,680 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.374, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.727, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.398, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.592, Oct 2024 – Sep 2025Better than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 8.6 (7.5 to 9.8) · 2,101 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Duke University Hospital
Behind the star rating — Deaths: 4 better, 3 the same, 1 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 216.01 (186.77 to 245.25) · 366 cases | Worse | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.5 (4.26 to 6.75) · 6,581 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.95 (2.11 to 3.79) · 3,680 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.374 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.727 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.398 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.592 | Better | Oct 2024 – Sep 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 8.6 (7.5 to 9.8) · 2,101 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.91 (0.21 to 1.61) · 4,083 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.1 (0.94 to 1.26) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.6 · 277 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 175 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.4 · 351 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 9.6 · 530 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.4 · 684 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.3 · 10,510 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.32) · 15,279 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.04 to 0.36) · 16,992 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.62 (1.69 to 3.56) · 5,880 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.88 (6.29 to 11.47) · 3,482 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (4.07 to 7.84) · 3,644 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.49 (1.26 to 3.72) · 1,495 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.5 (0.15 to 0.85) · 14,819 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.9 · 293 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 1.373 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.048 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.7 · 688 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 1,551 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 7.3 · 428 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -20.2 · 963 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -14.2 · 554 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.9 · 861 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (4.1 to 5.8) · 2,101 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.9 · 320 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.7 · 312 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.1 · 367 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.2 to 16) · 2,489 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1) · 2,623 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,341 patients answered, 22% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 90% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 82% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 78% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$41,533
Medicare paid this office $41,533 for 169 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 66 | $6,492 | $88 |
| Short return visit (20+ min) | 82 | $6,238 | $61 |
| New patient visit (30+ min) | 28 | $1,988 | $71 |
| Aspiration and/or injection of fluid from large joint | 16 | $909 | $48 |
| Injection, methylprednisolone acetate, 1 mg | 15 | $139 | None |
Procedures Medicare counted
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 1-10 | None |
| Upper limb (arm) arthroscopy (minimally invasive joint repair) | 28 | More than 72% of doctors who do this |
Who their Medicare patients are
169 Original Medicare patients in 2024. Average age 69 · Women 63% · Also on Medicaid 11% · Health risk score 1.16. Above the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 60% · Diabetes 23% · Coronary heart disease 20% · Depression 20% · Chronic kidney disease 19% · Cancer 14% · Atrial fibrillation 13% · Heart failure 12% · COPD 12% · Stroke 8%.
The office billed $231,300, Medicare allowed $53,962 and paid $41,533; for 1,619 services of 34 kinds; $190 of it was for drugs given in the office and $41,343 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 169 | 1,619 | 69 | 1.16 | $231,300 | $41,533 |
| 2023 | 152 | 316 | 68 | 1.02 | $147,655 | $29,391 |
| 2022 | 131 | 362 | 69 | 1.26 | $180,046 | $35,439 |
| 2021 | 136 | 284 | 68 | 1.17 | $234,035 | $45,985 |
| 2020 | 77 | 162 | 68 | 1.09 | $105,199 | $19,924 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Short return visit (20+ min) | 91 | $6,753 | $60 |
| Return visit (30+ min) | 49 | $4,269 | $85 |
| New patient visit (30+ min) | 18 | $1,240 | $69 |
| Aspiration and/or injection of fluid from large joint | 15 | $727 | $45 |
2022: 5 services
| Short return visit (20+ min) | 83 | $7,614 | $65 |
| Return visit (30+ min) | 30 | $2,678 | $84 |
| Aspiration and/or injection of fluid from large joint | 18 | $1,020 | $49 |
| New patient visit (30+ min) | 15 | $1,018 | $68 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $89 | None |
2021: 4 services
| Repair of shoulder rotator cuff using an endoscope | 12 | $11,027 | $848 |
| Short return visit (20+ min) | 86 | $7,039 | $64 |
| Return visit (30+ min) | 29 | $2,832 | $94 |
| New patient visit (30+ min) | 22 | $1,378 | $63 |
2020: 4 services
| Short return visit (20+ min) | 46 | $3,161 | $53 |
| New patient visit (30+ min) | 18 | $1,501 | $83 |
| New patient visit (45+ min) | 11 | $1,308 | $119 |
| Return visit (30+ min) | 12 | $1,012 | $78 |
Medicaid work
$7,795 in 2024
Medicaid paid $7,795 for 199 billed services this clinician did in 2024, up to 20 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 141 | $5,021 |
| Return visit (30+ min) | 58 | $2,774 |
| 2024 | 199 | 2 | 20 | $7,795 |
| 2023 | 169 | 2 | 25 | $6,510 |
| 2022 | 171 | 1 | 19 | $6,943 |
| 2021 | 102 | 1 | 18 | $4,807 |
| 2020 | 17 | 1 | 16 | $832 |
| 2018 | 32 | 1 | 19 | $15 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 157 | $5,713 |
| Return visit (30+ min) | 12 | $797 |
2022
| Short return visit (20+ min) | 171 | $6,943 |
2021
| Short return visit (20+ min) | 102 | $4,807 |
2020
| Short return visit (20+ min) | 17 | $832 |
2018
| Short return visit | 32 | $15 |
Drugs they prescribed that Part D paid
$1,565
Pharmacies billed $1,565 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 31% of their Part D prescriptions (61 of 200) in 2024. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 31%.
198 generic and fewer than 11 brand-name prescriptions · $1,565 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Oxycodone | 46 | $338 | $7 |
| Meloxicam | 36 | $203 | $6 |
| Ondansetron Odt | 24 | $111 | $5 |
| Naproxen | 16 | $102 | $6 |
| Methylprednisolone | 12 | $99 | $8 |
See all 7 drugs
| Oxycodone | 46 | $338 | $7 |
| Meloxicam | 36 | $203 | $6 |
| Ondansetron Odt | 24 | $111 | $5 |
| Naproxen | 16 | $102 | $6 |
| Methylprednisolone | 12 | $99 | $8 |
| Ibuprofen | 12 | $82 | $7 |
| Ondansetron | 17 | $67 | $4 |
Year by year
| 2024 | 200 | 80 | 31% (61) | None | $1,565 |
| 2023 | 182 | 69 | 26% (48) | None | $2,183 |
| 2022 | 150 | 57 | 41% (62) | 0% | $1,435 |
| 2021 | 141 | 53 | 61% (86) | None | $1,151 |
| 2020 | 63 | 25 | 51% (32) | 0% | $515 |
| 2019 | 29 | 16 | 45% (13) | None | $336 |
| 2018 | 17 | 15 | 77% (13) | 0% | $214 |
| 2017 | 35 | 32 | 89% (31) | None | $436 |
| 2015 | 14 | 11 | 93% (13) | None | $239 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Naproxen | 25 | $358 | $14 |
| Oxycodone | 42 | $258 | $6 |
| Meloxicam | 52 | $240 | $5 |
| Ondansetron | 15 | $94 | $6 |
| Ondansetron Odt | 18 | $79 | $4 |
2022: 4 drugs
| Oxycodone | 50 | $427 | $9 |
| Ondansetron | 24 | $195 | $8 |
| Meloxicam | 14 | $134 | $10 |
| Ondansetron Odt | 16 | $114 | $7 |
2021: 2 drugs
| Oxycodone | 66 | $450 | $7 |
| Ondansetron Odt | 23 | $143 | $6 |
2020: 2 drugs
| Oxycodone | 27 | $188 | $7 |
| Ondansetron Odt | 17 | $165 | $10 |
2019: 1 drug
| Oxycodone | 13 | $85 | $7 |
2017: 1 drug
| Hydrocodone-Acetaminophen | 16 | $118 | $7 |
Money from drug and device companies
$6,005 in 2025
| 2025 | 6 | 34 | $1,659 | $6,005 |
| 2024 | 5 | 8 | $3,375 | $3,989 |
| 2023 | 7 | 19 | $8,775 | $10,658 |
| 2022 | 4 | 8 | None | $2,949 |
| 2021 | 4 | 26 | None | $6,881 |
| 2020 | 3 | 10 | None | $2,438 |
| 2019 | 10 | 46 | None | $17,270 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Miach Orthopaedics | None | $4,124 | 3 payments
|
| Newclip USA | None | $1,304 | 2 payments
|
| TriCoast Surgical Solutions | None | $305 | 4 payments
|
| Stryker | Iconix | $112 | 1 payment
|
| Vericel | Maci | $101 | 2 payments
|
| DePuy Synthes Sales | Na | $59 | 1 payment
|
See all 13 published payments
| TriCoast Surgical Solutions | Meals · 2025-11-24 | None | $31 |
| TriCoast Surgical Solutions | Meals · 2025-07-30 | None | $72 |
| Newclip USA | Meals · 2025-07-25 | None | $104 |
| Newclip USA | Consulting · 2025-07-16 | None | $1,200 |
| TriCoast Surgical Solutions | Meals · 2025-06-25 | None | $130 |
| Miach Orthopaedics | Travel · 2025-06-19 | None | $2,848 |
| TriCoast Surgical Solutions | Meals · 2025-05-13 | None | $71 |
| Miach Orthopaedics | Consulting · 2025-05-12 | None | $459 |
| Vericel | Entertainment · 2025-05-09 | Maci | $72 |
| Miach Orthopaedics | Meals · 2025-05-05 | None | $817 |
| Stryker | Meals · 2025-05-04 | Iconix | $112 |
| Vericel | Meals · 2025-04-23 | Maci | $29 |
| DePuy Synthes Sales | Meals · 2025-02-09 | Na | $59 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $3,989
| Miach Orthopaedics | None | $3,375 | 1 payment
|
| Tricoast Surgical Solutions | None | $495 | 1 payment
|
| Smith+Nephew | None | $55 | 3 payments
|
| Moximed | Misha Knee System, Small, Left | $47 | 1 payment
|
| Vericel | Maci | $17 | 1 payment
|
2023: $10,658
| Miach Orthopaedics | None | $8,343 | 2 payments
|
| Stryker | Omega | $1,124 | 7 payments
|
| Medical Device Business Services | None | $675 | 1 payment
|
| Linvatec | Biobrace 23mm | $146 | 1 payment
|
| TriCoast Surgical Solutions | None | $132 | 1 payment
|
| International Life Sciences | None | $125 | 1 payment
|
| Vericel | Maci | $113 | 2 payments
|
2022: $2,949
| Arthrex | None | $1,452 | 4 payments
|
| Southtech Orthopedics | None | $1,200 | 1 payment
|
| Aesculap Biologics | Novocart 3d | $209 | 1 payment
|
| Medical Device Business Services | Bristow Latarjet | $88 | 2 payments
|
2021: $6,881
| Southtech Orthopedics | None | $4,800 | 4 payments
|
| Stryker | Na | $2,024 | 19 payments
|
| Smith+Nephew | Regeneten Shoulder | $34 | 2 payments
|
| Vericel | Maci | $23 | 1 payment
|
2020: $2,438
| Southtech Orthopedics | None | $2,007 | 2 payments
|
| Wright Medical Technology | Mica | $243 | 5 payments
|
| Stryker | Omega | $187 | 3 payments
|
2019: $17,270
| Smith+Nephew | None | $8,748 | 1 payment
|
| Djo | None | $2,188 | 2 payments
|
| Wright Medical Technology | Infinity | $2,004 | 22 payments
|
| Zimmer Biomet Holdings | Grants | $1,760 | 1 payment
|
| Stryker | Hip Arthroscopy Access & Instrumentation Set | $857 | 8 payments
|
| Crossroads Extremity Systems | None | $695 | 6 payments
|
| SouthTech Orthopedics | None | $624 | 2 payments
|
| Evolution Surgical | None | $155 | 2 payments
|
| Vericel | Maci | $125 | 1 payment
|
| DePuy Synthes Sales | Elite | $114 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Miach Orthopaedics, Inc. · Registry · 2024 | Their institution | $151,011 |
| Miach Orthopaedics, Inc. · A Prospective Cohort Post Market Registry Evaluating Outcomes of Bridge-Enhanced Acl Restoration (Bear) · 2025 | Their institution | $91,954 |
| Miach Orthopaedics, Inc. · Registry · 2023 | Their institution | $53,647 |
Professional record
- NPI
- 1154610327
- Licence
- CA A132046California A132046: Current · expires 2028-01-31
- Trained
- University of Pittsburgh School of Medicine, 2011
- Group
- Duke Health Integrated Practice Inc · Legacy Healthcare Services Inc
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Orthopedic surgery (207X00000X)
- Mailing address
- 3475 Erwin Rd, Durham, NC, 27705
- NPI first listed
- 2011-03-28
- NPI last updated
- 2020-10-30
- NPI record certified
- 2020-10-30
This is when the NPI record was last certified, not a medical board exam.